🇺🇸 FDA
Patent

US 8048889

3,4-disubstituted coumarin and quinolone compounds

granted A61KA61K31/366A61K31/4025

Quick answer

US patent 8048889 (3,4-disubstituted coumarin and quinolone compounds) held by XTL BIOPHARMACEUTICALS LTD. expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XTL BIOPHARMACEUTICALS LTD.
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/366, A61K31/4025, A61K31/4433, A61K31/4709